Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Expert Opinion on Drug Delivery
|
September 19, 2009
Strategies for the targeted delivery of therapeutics for osteosarcoma
Dennis P M Hughes
Current Opinion in Oncology
|
May 16, 2009
Novel agents in development for pediatric sarcomas
Dennis P M Hughes
Cancer Treatment and Research
|
March 10, 2010
How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize
Dennis P M Hughes
Current Oncology Reports
|
October 21, 2009
Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions
Mandy Geryk-Hall, Dennis P M Hughes
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2014
New, tolerable γ-secretase inhibitor takes desmoid down a notch
Dennis P M Hughes, Shivaani Kummar, Alexander J Lazar
Advances in Experimental Medicine and Biology
|
June 14, 2014
Developmental pathways hijacked by osteosarcoma
Jared R Mortus, Yi Zhang, Dennis P M Hughes
Molecular Cancer Therapeutics
|
April 22, 2010
Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected]
Mandy Geryk-Hall, Yanwen Yang, Dennis P M Hughes
Frontiers in Oncology
|
September 25, 2013
Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression
Limin Zhu, Madonna M McManus, Dennis P M Hughes
Paediatric Drugs
|
May 24, 2015
Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy
Rocio K Rivera-Valentin, Limin Zhu, Dennis P M Hughes
Advances in Experimental Medicine and Biology
|
June 14, 2014
Understanding the role of Notch in osteosarcoma
Madonna M McManus, Kurt R Weiss, Dennis P M Hughes
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Expert Opinion on Drug Delivery
|
September 19, 2009
Strategies for the targeted delivery of therapeutics for osteosarcoma
Dennis P M Hughes
Current Opinion in Oncology
|
May 16, 2009
Novel agents in development for pediatric sarcomas
Dennis P M Hughes
Cancer Treatment and Research
|
March 10, 2010
How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize
Dennis P M Hughes
Current Oncology Reports
|
October 21, 2009
Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions
Mandy Geryk-Hall, Dennis P M Hughes
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2014
New, tolerable γ-secretase inhibitor takes desmoid down a notch
Dennis P M Hughes, Shivaani Kummar, Alexander J Lazar
Advances in Experimental Medicine and Biology
|
June 14, 2014
Developmental pathways hijacked by osteosarcoma
Jared R Mortus, Yi Zhang, Dennis P M Hughes
Molecular Cancer Therapeutics
|
April 22, 2010
Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected]
Mandy Geryk-Hall, Yanwen Yang, Dennis P M Hughes
Frontiers in Oncology
|
September 25, 2013
Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression
Limin Zhu, Madonna M McManus, Dennis P M Hughes
Paediatric Drugs
|
May 24, 2015
Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy
Rocio K Rivera-Valentin, Limin Zhu, Dennis P M Hughes
Advances in Experimental Medicine and Biology
|
June 14, 2014
Understanding the role of Notch in osteosarcoma
Madonna M McManus, Kurt R Weiss, Dennis P M Hughes
Page
of 3